A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines

被引:58
作者
Chopin, LK [1 ]
Herington, AC [1 ]
机构
[1] Queensland Univ Technol, Sch Life Sci, Ctr Mol Biotechnol, Brisbane, Qld 4001, Australia
关键词
growth hormone releasing hormone; growth hormone releasing hormone receptor; ALVA-41; DU145; PC3; LNCaP;
D O I
10.1002/pros.1125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Recent studies have shown that GHRH antagonists inhibit prostate tumour growth and IGF-II production both in vivo and in vitro. The mechanism underlying these observations is unknown, but may involve an interaction with a prostatic GHRH receptor (GHRH-R), raising the possibility of an autocrine pathway for the GHRH axis in the prostate. Methods. GHRH and GHRH-R mRNA expression was examined by RT-PCR in human prostate cancer cell lines, and the authenticity of PCR products was confirmed by Southern analysis and cDNA sequencing. Immunohistochemical techniques were used to examine the expression of GHRH protein in prostate cancer cell lines. Results. GHRH-R (mRNA) and GHRH (mRNA and protein) are co-expressed in the ALVA-41, DU145, LNCaP and PC3 human prostate cancer cell lines. Conclusions. These observations suggest the presence of an intact prostatic GHRH autocrine pathway which may stimulate prostate cell proliferation. This pathway may be disrupted by GHRH antagonists. Prostate 49: 116-121, 2007, (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 30 条
[1]   IMMUNOHISTOLOGICAL LOCALIZATION OF GROWTH HORMONE-RELEASING HORMONE IN HUMAN-TUMORS [J].
ASA, SL ;
KOVACS, K ;
THORNER, MO ;
LEONG, DA ;
RIVIER, J ;
VALE, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (03) :423-427
[2]   Plasma insulin-like growth factor I and prostate cancer risk: A prospective study [J].
Chan, JM ;
Stampfer, MJ ;
Giovannucci, E ;
Gann, PH ;
Ma, J ;
Wilkinson, P ;
Hennekens, CH ;
Pollak, M .
SCIENCE, 1998, 279 (5350) :563-566
[3]  
CHOPIN L, 1999, CLIN BIOCHEM REV, V20, P3
[4]   Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro [J].
Csernus, V ;
Schally, AV ;
Groot, K .
PEPTIDES, 1999, 20 (07) :843-850
[5]   Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro [J].
Csernus, VJ ;
Schally, AV ;
Kiaris, H ;
Armatis, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3098-3103
[6]  
Cutting CWM, 1999, BJU INT, V83, P996
[7]   Tissue-specific molecular heterogeneity of human growth hormone-releasing hormone receptor protein [J].
Fujinaka, Y ;
Yokogoshi, Y ;
Zhang, CY ;
Okura, T ;
Kitagawa, K ;
Saito, S .
FEBS LETTERS, 1996, 394 (01) :1-4
[8]  
Gkonos PJ, 2000, PROSTATE, V42, P137
[9]   Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone [J].
Halmos, G ;
Schally, AV ;
Varga, JL ;
Plonowski, A ;
Rekasi, Z ;
Czompoly, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10555-10560
[10]   Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone [J].
Jungwirth, A ;
Schally, AV ;
Pinski, J ;
Halmos, G ;
Groot, K ;
Armatis, P ;
VadilloBuenfil, M .
BRITISH JOURNAL OF CANCER, 1997, 75 (11) :1585-1592